Forma Therapeutics - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Forma Therapeutics M&A Summary

Forma Therapeutics has acquired 1 company of its own.

Forma Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include healthcare services (100%).

Forma Therapeutics Ownership

Who owns Forma Therapeutics?

Forma Therapeutics is owned by Novo Nordisk A/S. It was acquired on September 1, 2022.

Forma Therapeutics Business Overview

Where is Forma Therapeutics headquartered?

Forma Therapeutics is headquartered in Watertown, Massachusetts.

What is Forma Therapeutics’ revenue?

Forma Therapeutics disclosed revenue of 101M USD for 2019 and 164M USD for 2018.

How many employees does Forma Therapeutics have?

Forma Therapeutics has 114 employees.

What sector is Forma Therapeutics in?

Forma Therapeutics is a life science company.

When was Forma Therapeutics founded?

Forma Therapeutics was founded in 2007.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Forma Therapeutics

Forma Therapeutics, Inc.

300 North Beacon Street, Suite 501,
Watertown, Massachusetts 02472
United States,
(617) 679-1970
www.formatherapeutics.com

Forma Therapeutics is a fully-integrated, privately-held clinical-stage biopharmaceutical company. A leader in metabolism, epigenetics, and protein homeostasis focused on the discovery, development, and commercialization of transformative medicines. It's proprietary R&D platform combines deep biology insight, chemistry expertise, and clinical development capabilities to create differentiated drug candidates. The company has delivered high-value clinical candidates to its partners and generated a broad proprietary portfolio of internal programs, ranging from pre-clinical to pivotal-stage, with the potential to provide profound patient benefit in hematologic, oncologic and metabolic indications. Forma Therapeutics was formed in 2007 and is based in Watertown, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Solmap Pharmaceuticals, Inc. 2008-09-30 - Add-on Acquisition
Cambridge, Massachusetts
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Healthcare Services 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  Massachusetts 1 - - -
Total 1 - - -

 Subscribe to unlock this and 201,535
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.